
Srinivasa Venkatavaradhan Raghavan
About Srinivasa Venkatavaradhan Raghavan
Data last updated:
Srinivasa Venkatavaradhan Raghavan has 22 years in corporate governance. Holds Designated Partner and Director roles. Currently with 6 companies, including Hcg Oncology Hospitals Llp and Hcg Nchri Oncology Llp. Formerly with 14 companies, such as Healthcare Global Enterprises Limited and Computer Sciences Corporation India Private Limited. Engaged in General Business, Technology and more. The 5 current companies with reported revenue have a combined latest revenue of ₹561 Cr; the largest is Hcg Medi-Surge Hospitals Private Limited at ₹241 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Jul 2020 | 2000 | ₹241 Cr (FY 2025) | Active | |
| Designated Partner | 24 Aug 2019 | 2016 | ₹100 Cr (FY 2022) | Active | |
| Nominee Director | 18 Nov 2021 | 2011 | ₹97.77 Cr (FY 2025) | Active | |
| Designated Partner | 24 Aug 2019 | 2013 | ₹63.00 Cr (FY 2023) | Active | |
| Director | 27 Nov 2020 | 2002 | ₹58.38 Cr (FY 2025) | Active | |
| Designated Partner | 24 Aug 2019 | 2014 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Cfo | 27 Jul 2018 | 1998 | ₹2,258 Cr (FY 2025) | Active | |
| Director | 20 Jun 2014 | 1996 | ₹163 Cr (FY 2025) | Active | |
| Whole-Time Director | 07 Oct 2015 | 2015 | ₹2,287 Cr (FY 2025) | Active | |
| Director | 06 Jun 2016 | 2002 | ₹202 Cr (FY 2025) | Active | |
| Director | 03 Sep 2004 | 1998 | – | Amalgamated | |
| Director | 02 Jan 2016 | 2016 | ₹52 Lakh (FY 2020) | Amalgamated | |
| Additional Director | 13 Jan 2017 | 2013 | – | Active | |
| Additional Director | 06 Mar 2017 | 2012 | – | Amalgamated | |
| Director | 20 Jun 2014 | 2000 | – | Amalgamated | |
| Director | 20 Jun 2014 | 1998 | – | Amalgamated | |
| Director | 20 Jun 2014 | 2001 | – | Amalgamated | |
| Director | 20 Jun 2014 | 1993 | – | Amalgamated | |
| Director | 20 Jun 2014 | 2003 | – | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Srinivasa Venkatavaradhan Raghavan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srinivasa Venkatavaradhan Raghavan
Srinivasa Venkatavaradhan Raghavan has 22 years in corporate governance. Holds Designated Partner and Director roles. Currently with 6 companies, including Hcg Oncology Hospitals Llp and Hcg Nchri Oncology Llp. Formerly with 14 companies, such as Healthcare Global Enterprises Limited and Computer Sciences Corporation India Private Limited. Engaged in General Business, Technology and more. The 5 current companies with reported revenue have a combined latest revenue of ₹561 Cr; the largest is Hcg Medi-Surge Hospitals Private Limited at ₹241 Cr (FY 2025).
Srinivasa Venkatavaradhan Raghavan is associated with 6 companies as Designated Partner and Director, including Hcg Medi-Surge Hospitals Private Limited (₹241 Cr), Hcg Manavata Oncology Llp (₹100 Cr), Suchirayu Health Care Solutions Limited (₹97.77 Cr).
Srinivasa Venkatavaradhan Raghavan has expertise in General Business, Technology and other sectors.
Srinivasa Venkatavaradhan Raghavan has 22 years in corporate governance.
By reported revenue, the largest current company of Srinivasa Venkatavaradhan Raghavan is Hcg Medi-Surge Hospitals Private Limited, with revenue of ₹241 Cr (FY 2025).
The 5 current companies of Srinivasa Venkatavaradhan Raghavan that report revenue have a combined latest revenue of ₹561 Cr.
Srinivasa Venkatavaradhan Raghavan currently holds positions at 6 companies; the 5 largest by reported revenue are Hcg Medi-Surge Hospitals Private Limited (₹241 Cr), Hcg Manavata Oncology Llp (₹100 Cr), Suchirayu Health Care Solutions Limited (₹97.77 Cr), Hcg Oncology Hospitals Llp (₹63.00 Cr), Bacc Health Care Private Limited (₹58.38 Cr).